SANDHYA JAIN: Open Payments
NPI 1023500972 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 59 payments from 18 companies in 2025. Trend: 2023 $543 · 2024 $794 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $351 |
| Vanda Pharmaceuticals Inc. | 8 | $267 |
| Neurocrine BioSciences, Inc. | 3 | $93 |
| Indivior Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Alkermes, Inc. | 2 | $39 |
| Sage Therapeutics, LLC | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Exact Sciences Corporation | 2 | $30 |
| Viatris Specialty LLC | 1 | $27 |
Products named: CAPLYTA, HETLIOZ, INGREZZA, FANAPT, SUBLOCADE, SPRAVATO, ARISTADA, ZURZUVAE.
Industry payments across MI — which companies pay providers there.
